Avadel Pharmaceuticals
AVDL
$17.81
Share price
-0.06%
Change (1 day)
76.51%
Change (1 year)
Categories
P/S ratio for Avadel Pharmaceuticals (AVDL)
P/S ratio as of April 2024 (TTM): 57.7
According to Avadel Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 57.6897. At the end of 2023 the company had a P/S ratio of 45.3.
P/S ratio history for Avadel Pharmaceuticals from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 45.3 | |
| 2022 | N/A | |
| 2021 | N/A | -100% |
| 2020 | 17.4 | 265.01% |
| 2019 | 4.77 | 416.39% |
| 2018 | 0.9247 | -50.87% |
| 2017 | 1.88 | -34.01% |
| 2016 | 2.85 | -2.58% |
| 2015 | 2.93 | -97.27% |
| 2014 | 107 | 1068.4% |
| 2013 | 9.19 | 217.03% |
| 2012 | 2.90 | -27.36% |
| 2011 | 3.99 | -12.22% |
| 2010 | 4.54 | 6.26% |
| 2009 | 4.28 | 74.07% |
| 2008 | 2.46 | -62.48% |
| 2007 | 6.55 | -79.02% |
| 2006 | 31.2 | 64.56% |
| 2005 | 19.0 | 207.62% |
| 2004 | 6.17 | -73.32% |
| 2003 | 23.1 | 502.17% |
| 2002 | 3.84 | 13.99% |
| 2001 | 3.37 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.02 | -98.24% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 60.34% | 🇺🇸 USA |